Salbutamol
ADVERTISEMENT
- Molecular formula
- C13H21NO3
- CAS Number
- 18559-94-9
- IUPAC Name
- 4-[1-hydroxy-2-[(1-methyl-3-phenyl-propyl)amino]propyl]phenol
- Molecular Weight
- 239.31g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.3500g/cm3
- Synonyms
- nylidrin
Identification
Interesting facts
Interesting Facts about 4-[1-hydroxy-2-[(1-methyl-3-phenyl-propyl)amino]propyl]phenol
This intriguing compound, with its complex structure, has piqued the interest of chemists and pharmacologists alike. Here are some fascinating insights about 4-[1-hydroxy-2-[(1-methyl-3-phenyl-propyl)amino]propyl]phenol:
- Biological Activity: This compound is often explored for its potential in the field of pharmaceuticals, particularly regarding its role as a drug candidate. The presence of the hydroxyphenyl group may influence its interaction with biological targets.
- Potential Applications: Due to its structural characteristics, it is hypothesized that this compound might exhibit properties beneficial for treating certain disorders, although further research is necessary to fully understand its effects.
- Synthetic Routes: The synthesis of this compound can involve various methods, highlighting the versatility and creativity required in organic synthesis. Chemists often experiment with different reagents and conditions to optimize yields.
- Interaction with Receptors: The unique amine structure suggests possible interactions with various receptor types in biological systems, which can lead to interdisciplinary studies bridging chemistry and biology.
- Structural Complexity: The compound's intricate design includes multiple functional groups, allowing for diverse reactivity and potentially leading to a range of derivatives with tailored properties.
In summary, 4-[1-hydroxy-2-[(1-methyl-3-phenyl-propyl)amino]propyl]phenol exemplifies the exciting intersection of synthetic chemistry and pharmacology. The ongoing research into its applications not only fuels scientific inquiry but also showcases the potential for developing innovative therapeutic agents.